General Anesthesia Practice Questions

Q: What is the definition of conscious sedation?

Sedation with ability to respond to verbal commands. ***Sedation with ability to respond to verbal commands*** - Conscious sedation involves a drug-induced depression of consciousness during which the patient **retains the ability to respond purposefully to verbal commands**. - This level of sedation ensures that the patient's **airway reflexes** and **ventilatory function** remain intact. *CNS depression with unconsciousness* - This describes **general anesthesia** or **deep sedation**, where the patient is unable to respond purposefully to verbal commands. - In such states, spontaneous ventilation may be **inadequate**, and **airway support** is often required. *Sedation with inability to respond to verbal commands* - This definition aligns with **deep sedation** or **general anesthesia**, where the patient's consciousness is significantly depressed. - At this level, patients may require assistance in maintaining a **patent airway** and adequate ventilation. *None of the options* - This option is incorrect because one of the provided definitions accurately describes conscious sedation. - The definition of conscious sedation is well-established in clinical practice, emphasizing the **preservation of responsiveness**.

Q: Which of the following anesthetic agents causes the LEAST severe complications when accidentally injected intra-arterially?

Propofol. **Propofol** * **Propofol** has a relatively low incidence and severity of complications if accidentally injected intra-arterially because of its **lipid emulsion formulation** and mild irritant properties compared to other agents. * While any intra-arterial injection can cause problems, the milder venoconstriction and less direct tissue damage make its intra-arterial complication profile less severe than alternative agents. *Thiopentone* * **Thiopentone** (Thiopental) is highly alkaline, and accidental intra-arterial injection can cause **intense pain**, **vasospasm**, and **gangrene** due to precipitation in the arterioles and widespread endothelial damage. * This severe complication arises from its extreme pH and crystal formation, leading to profound ischemia. *Midazolam* * Accidental intra-arterial injection of **Midazolam** can cause **pain**, **spasm**, and **local tissue damage** due to its relatively acidic pH and solvent properties, though generally less severe than thiopentone. * While not as catastrophic as thiopentone, it can still lead to significant discomfort and localized vascular issues. *Methohexitone* * **Methohexitone** is also an alkaline barbiturate derivative, similar in nature to thiopentone, and its intra-arterial injection carries a significant risk of **vasospasm**, **pain**, and potentially **tissue necrosis**. * Its strong irritant properties and ability to precipitate within the vasculature make it a dangerous agent for inadvertent intra-arterial administration.

Q: Which anaesthetic is contraindicated in renal failure?

Methoxyflurane. ***Methoxyflurane*** - Methoxyflurane undergoes significant **metabolism** to produce inorganic **fluoride ions**, which are directly **nephrotoxic**. - This nephrotoxicity can cause **high-output renal failure** with reduced concentrating ability, making it contraindicated in patients with pre-existing renal impairment. *Isoflurane* - Isoflurane is minimally metabolized and produces very low levels of **fluoride ions**, making it generally **safe** for use in patients with renal failure. - Its elimination is primarily via the **lungs**, with very little hepatic metabolism or renal excretion of active compounds. *Desflurane* - Desflurane is also minimally metabolized, similar to isoflurane, and therefore produces negligible amounts of **fluoride ions**. - It is considered a **safe option** for patients with renal impairment due to its predominantly pulmonary elimination and lack of nephrotoxic metabolites. *Halothane* - While halothane can cause **hepatotoxicity**, it is generally **not directly nephrotoxic** in the way methoxyflurane is. - Its metabolism, though more extensive than isoflurane or desflurane, does not produce clinically significant levels of nephrotoxic fluoride ions to contraindicate its use in renal failure.

Q: Which anesthetic agent is known for providing smooth induction?

Isoflurane. ***Isoflurane*** - **Isoflurane** is frequently chosen for its capacity to induce a **smooth and rapid loss of consciousness**, primarily due to its low blood solubility which facilitates quick changes in anesthetic depth. - Its **minimal irritation** to the respiratory tract and **stable cardiovascular profile** during induction contribute to a smoother process for the patient. *Sevoflurane* - While sevoflurane also offers a **smooth and rapid induction** due to its low solubility, it is sometimes associated with a higher incidence of **airway irritation** (e.g., coughing) compared to isoflurane, especially in children. - It is known for its **pleasant odor**, making it a good choice for mask induction in pediatric patients. *Halothane* - **Halothane** provides a relatively smooth induction but has a higher risk of **hepatotoxicity** and cardiac arrhythmias, which have led to its decreased use. - Its higher blood solubility means a **slower onset and offset** compared to modern volatile agents like isoflurane. *Enflurane* - **Enflurane** can cause **CNS excitation** at deeper levels of anesthesia, potentially leading to seizures, making its induction less smooth and predictable. - It also has a greater potential to cause **myocardial depression** and arrhythmias than isoflurane.

Q: Who coined the term "balanced anaesthesia"?

Lundy (John S. Lundy). ***Lundy (John S. Lundy)*** - **John S. Lundy** is credited with coining the term "**balanced anaesthesia**" in the early 20th century. - This concept describes the use of **multiple anesthetic agents** in combination, each contributing to different aspects of anesthesia (e.g., hypnosis, analgesia, muscle relaxation). *Simpson* - **Sir James Young Simpson** was a Scottish physician who pioneered the use of **chloroform** and ether as anesthetics in the mid-19th century. - While he significantly advanced the field of anesthesia, he did not coin the term "balanced anaesthesia." *Fischer* - **Emil Fischer** was a German chemist who won the Nobel Prize in Chemistry for his work on sugar and purine syntheses. - His contributions were primarily in organic chemistry and biochemistry, not directly in the field of clinical anesthesia terminology. *Morton* - **William T.G. Morton** was an American dentist who famously demonstrated the first public use of **ether** for surgical anesthesia in 1846. - He is known for popularizing ether as a surgical anesthetic but did not coin the term "balanced anaesthesia."

Q: Which of the following statements about Nitrous Oxide (N2O) is true?

Least potent inhalational anesthetic. **Least potent inhalational anesthetic** - Nitrous oxide has a **high Minimum Alveolar Concentration (MAC)** of approximately 104%, making it the least potent of the commonly used inhalational anesthetics. - Its high MAC means a very high concentration is required to achieve surgical anesthesia, which is why it is typically used as an adjunct to more potent agents. *Lighter than air* - The molecular weight of nitrous oxide (N2O) is 44, which is **heavier than air** (average molecular weight approximately 29 g/mol). - Its density is greater than air, meaning it would tend to sink rather than rise. *Effective muscle relaxant* - Nitrous oxide provides **minimal to no skeletal muscle relaxation** benefits. - If muscle relaxation is required, a neuromuscular blocking agent must be administered separately. *Does not cause diffusion hypoxia* - Nitrous oxide rapidly diffuses out of the blood into the alveoli during emergence, diluting the oxygen and carbon dioxide there. - This rapid diffusion can lead to **diffusion hypoxia** (also known as the "second gas effect"), necessitating the administration of 100% oxygen during recovery to prevent this complication.

Q: Which anesthetic agent is known for the fastest induction and recovery?

N2O. ***N2O*** - **Nitrous oxide** has a very **low blood-gas partition coefficient** (0.47), meaning it quickly saturates the blood and brain, leading to rapid induction and recovery. - Its **low solubility** allows for fast changes in anesthetic depth as it moves rapidly in and out of the bloodstream. *Desflurane* - While Desflurane also has a **low blood-gas partition coefficient** (0.42) and provides rapid induction and recovery, **N2O** is generally recognized as having the fastest kinetics. - Desflurane's volatility often requires a specialized heated vaporizer due to its **low boiling point**. *Halothane* - Halothane has a **higher blood-gas partition coefficient** (2.4) compared to N2O and desflurane, resulting in a slower induction and recovery time. - It is associated with potential **hepatotoxicity** (halothane hepatitis) and is no longer widely used. *Enflurane* - Enflurane has an intermediate **blood-gas partition coefficient** (1.9), making its induction and recovery slower than N2O, desflurane, and sevoflurane. - It can cause **seizures** at high concentrations and is also largely replaced by newer agents.

Q: What is the primary clinical use of Sugammadex in anesthesia?

Reversal of NM blockers. ***Reversal of NM blockers*** - **Sugammadex** is a modified gamma-cyclodextrin that specifically encapsulates steroidal **neuromuscular blocking agents (NMBAs)** like **rocuronium** and **vecuronium**. - This encapsulation rapidly inactivates the NMBAs, leading to a dose-dependent and swift **reversal of neuromuscular blockade**. *Organophosphate poisoning* - Organophosphate poisoning is treated with **atropine** to block muscarinic effects and **pralidoxime** to reactivate inhibited acetylcholinesterase. - Sugammadex has no role in antagonizing the effects of **organophosphates** or regenerating acetylcholinesterase. *Treatment of local anaesthetic poisoning* - Local anesthetic systemic toxicity (LAST) is primarily managed with supportive care, including airway management, and the administration of **lipid emulsion therapy**. - Sugammadex does not bind to local anesthetics and therefore has no efficacy in treating local anesthetic poisoning. *Treatment of central anticholinergic syndrome* - Central anticholinergic syndrome is typically treated with **physostigmine**, an acetylcholinesterase inhibitor that can cross the blood-brain barrier. - Sugammadex is not an anticholinergic antagonist and does not affect the central nervous system to reverse anticholinergic effects.

Q: Phase II block is seen with:

SCh infusion. ***SCh infusion*** - A **prolonged infusion or high dose** of succinylcholine (SCh) can lead to a **Phase II block**, a desensitizing block resembling that of a non-depolarizing neuromuscular blocker. - This occurs due to the **persistent presence of SCh** at the neuromuscular junction, which initially depolarizes the endplate (Phase I) but eventually leads to **receptor desensitization** and repolarization, preventing further muscle contraction. *Single dose SCh* - A **single bolus dose of succinylcholine** typically produces a **Phase I block**, characterized by initial muscle fasciculations followed by flaccid paralysis due to persistent depolarization of the motor endplate. - It resolves relatively quickly as **succinylcholine is rapidly hydrolyzed** by pseudocholinesterase, usually not leading to a prolonged desensitization characteristic of Phase II. *Mivacurium* - **Mivacurium** is an intermediate-acting, **non-depolarizing neuromuscular blocker**. - Its mechanism of action involves **competitively binding to nicotinic acetylcholine receptors** at the neuromuscular junction, thereby preventing acetylcholine from binding and initiating muscle contraction, which is fundamentally different from a Phase II block caused by prolonged depolarization. *None of the options* - This option is incorrect because **SCh infusion** is a recognized cause of Phase II block. - The phenomenon of Phase II block is a well-established pharmacological response to **excessive and prolonged exposure** to depolarizing neuromuscular blockers like succinylcholine.

Q: Which anaesthetic agent has maximum MAC ?

Nitrous Oxide (N2O). ***Nitrous Oxide (N2O)*** - **Nitrous Oxide** has the highest **minimum alveolar concentration (MAC)** of all commonly used inhalational anesthetics, approximately 104%. - A high MAC indicates **low potency**, meaning that a large concentration is required to achieve anesthetic effects. *Ether* - **Ether** has a MAC of about 1.92%, which is significantly lower than that of Nitrous Oxide. - Its use has largely been replaced due to its flammability, slow induction, and recovery times. *Methoxyfluorane* - **Methoxyfluorane** is known for having a very low MAC, around 0.16%, making it the most potent inhalational anesthetic. - Due to its high potency and significant nephrotoxicity, its use is now very limited. *Halothane* - **Halothane** has a MAC of approximately 0.75%. - While it was a widely used inhalational anesthetic, it has largely been replaced due to concerns about **halothane hepatitis** and arrhythmogenicity.

Question 1

What is the definition of conscious sedation?

Accepted Answer

Sedation with ability to respond to verbal commands

Answer

CNS depression with unconsciousness

Answer

Sedation with inability to respond to verbal commands

Answer

None of the options

Question 2

Which of the following anesthetic agents causes the LEAST severe complications when accidentally injected intra-arterially?

Accepted Answer

Propofol

Answer

Thiopentone

Answer

Methohexitone

Answer

Midazolam

Question 3

Which anaesthetic is contraindicated in renal failure?

Accepted Answer

Methoxyflurane

Answer

Isoflurane

Answer

Desflurane

Answer

Halothane

Question 4

Which anesthetic agent is known for providing smooth induction?

Accepted Answer

Isoflurane

Answer

Halothane

Answer

Enflurane

Answer

Sevoflurane

Question 5

Who coined the term "balanced anaesthesia"?

Accepted Answer

Lundy (John S. Lundy)

Answer

Simpson

Answer

Fischer

Answer

Morton

Question 6

Which of the following statements about Nitrous Oxide (N2O) is true?

Accepted Answer

Least potent inhalational anesthetic

Answer

Lighter than air

Answer

Effective muscle relaxant

Answer

Does not cause diffusion hypoxia

Question 7

Which anesthetic agent is known for the fastest induction and recovery?

Accepted Answer

N2O

Answer

Halothane

Answer

Enflurane

Answer

Desflurane

Question 8

What is the primary clinical use of Sugammadex in anesthesia?

Accepted Answer

Reversal of NM blockers

Answer

Organophosphate poisoning

Answer

Treatment of local anaesthetic poisoning

Answer

Treatment of central anticholinergic syndrome

Question 9

Phase II block is seen with:

Accepted Answer

SCh infusion

Answer

Single dose SCh

Answer

Mivacurium

Answer

None of the options

Question 10

Which anaesthetic agent has maximum MAC ?

Accepted Answer

Nitrous Oxide (N2O)

Answer

Ether

Answer

Methoxyfluorane

Answer

Halothane

General Anesthesia — MCQs

General Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?